BOCA RATON, FL., September 21, 2024– PharmaLogic Holdings, Inc. (“PharmaLogic”), the leading independent contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, announced the company will participate in two panel discussions as part of this year’s Redburn Atlantic x Rothschild & Co. Radiopharma Landscape Conference on Wednesday, 26 September.
Radiopharma Landscape | 10:05 EDT | Etienne Montagut, President
Radiopharmaceutical Supply Chain and Manufacturing | 11:15 EDT | Scott Holbrook, Chief Strategy Officer and GM
About PharmaLogic Holdings Corp.
PharmaLogic is the leading independent contract development and manufacturing organization (CDMO)specialized in novel diagnostic and therapeutic radiopharmaceuticals used for the treatment of cancers, neurodegenerative conditions and other diseases. In addition to best-in-class infrastructure in North America, PharmaLogic has decades of expertise in supporting Pharmaceutical Companies with modular manufacturing, end-to-end distribution, and related development services. For more information, visit www.radiopharmacy.com.